The role of cardiorenal biomarkers for risk stratification in the early follow-up after hospitalisation for acute heart failure
| Field | Value |
|---|---|
| Model ID | 13-103-01 |
| Model Name | Tolonen 2013 |
| Pubmed ID | 23879546 |
| First Author | Tolonen |
| Journal | Biomarkers |
| Year | 2013 |
| Title | The role of cardiorenal biomarkers for risk stratification in the early follow-up after hospitalisation for acute heart failure |
| Primary Index Condition | Chronic Heart Failure (CHF) |
| Secondary Index Condition | N/A |
| Outcome | Composite |
| Model Sample Size | 124 |
| Cohort Sample Size | 124 |
| Number of Events | 33 |
| Follow-Up Duration | Moderate (3-6 months) |
| AUROC | 0.7 |
| Calibration Reported | 1 |
| Covariates | W5 NT-proBNP Q4 (>=4972 pg/ml); W5 cystatin >= median (1.33 mg/l); Lack of >=30% decrease in NT-proBNP; W5 troponin I positivity (>=0.035 ug/l) |
| Mesh Terms | To be updated |
| Number of Validations | 0 |